SK-464

N/A

Report date: 2022/01/14 13:56:11
NME

Base Information

Drug NameSK-464
Drug Alias NameSK-464
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDCN1-like protein 1 inhibitorsNEDD8-conjugating enzyme Ubc12 inhibitors
TargetsDCN1-like protein 1NEDD8-conjugating enzyme Ubc12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhengzhou University
China Registration ClassN/A

Develop Information

Active CompaniesZhengzhou University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A